Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes 
Armani Group Eyes Strategic Stake Sale to Luxury Giants 
CSL Shares Crash as Profit Warning and $5 Billion Impairment Shake Investors 
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 
Broadcom Eyes $35 Billion AI Chip Financing Deal With Apollo and Blackstone 
Goldman Sachs Delays Fed Rate Cut Forecast to 2026 Amid Rising Inflation Concerns 
Sony Forecasts Lower 2027 Profit Despite Strong Music and Sensor Growth 
Trump Administration Seeks Court Pause to Reinstate 10% Global Tariffs 
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 
Reliance Industries Reworks Jio IPO Into Fresh Share Sale Amid Valuation Talks 
Judge Delays SEC Settlement With Elon Musk Over Twitter Stock Disclosure Case 
Aker BP Q1 Profit Jumps on Higher Oil Prices and Asset Reversal 
Trump DOJ Challenges Colorado’s Large-Capacity Magazine Ban in Second Amendment Lawsuit 
TikTok Nears $400 Million Settlement With Trump Administration Over Child Privacy Lawsuit 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 
Orsted Q1 EBITDA Beats Expectations Despite U.S. Impairments 
Australia’s health regulator, the Therapeutic Goods Administration (TGA), has launched legal action against News Corp Australia-owned News Life Media, Mamamia.com.au, AG Therapeutics, and public relations firm Straight Up PR for allegedly breaching medicinal cannabis advertising laws.
The TGA is seeking financial penalties, claiming the companies unlawfully advertised prescription-only cannabis products, violating the Therapeutic Goods Act 1989. The Act strictly prohibits the promotion of prescription medicines, including medicinal cannabis, to the public without prior authorization.
According to the TGA, articles published by News Life Media and Mamamia featured illegal testimonials and endorsements from healthcare professionals and individuals associated with patients, which are banned under Australian advertising codes. The watchdog also accused AG Therapeutics of using euphemisms like “plant medicine” in its marketing while promoting cannabis as a treatment for serious health conditions across its website and social media platforms.
TGA head Anthony Lawler said the parties involved had previously received multiple warnings regarding the unlawful promotion of therapeutic goods. Despite these alerts, the alleged advertising continued.
News Corp Australia, a unit of global media giant News Corp (NASDAQ:NWSA), has not responded to media inquiries about the proceedings. The case highlights the growing scrutiny over cannabis advertising and the regulator’s commitment to enforcing compliance in the rapidly expanding medicinal cannabis sector.
The lawsuit signals a warning to media outlets, natural health brands, and PR firms engaging in unapproved promotions of prescription therapies. As cannabis becomes more mainstream in Australia, businesses are urged to align with legal frameworks to avoid regulatory penalties and reputational damage.
This case also emphasizes the importance of responsible marketing in the health and wellness industry, particularly when dealing with prescription-only products like medicinal cannabis.
